The efficacy of different doses of solifenacin in elderly patients after treating a urinary tract infectionFootnote

Peer review under responsibility of Arab Association of Urology.

References

• T.A.RoweM.Juthani-MehtaUrinary tract infection in older adultsAging Health952013 10.2217/ahe.13.38
   Google Scholar
• I.ErikssonY.GustafsonL.FagerströmB.OlofssonDo urinary tract infections affect morale among very old women?Health Qual Life Outcomes8201073
   PubMed Web of Science ®Google Scholar
• S.J.MatthewsJ.W.LancasterUrinary tract infections in the elderly populationAm J Geriatr Pharmacother92011286309
   PubMedGoogle Scholar
• T.A.RoweM.Juthani-MehtaDiagnosis and management of urinary tract infection in older adultsInfect Dis Clin North Am2820147589
   PubMed Web of Science ®Google Scholar
• L.ModyM.Juthani-MehtaUrinary tract infections in older women: a clinical reviewJAMA3112014844854
   PubMed Web of Science ®Google Scholar
• D.de RidderT.RoumeguèreL.KaufmanOveractive bladder symptoms, stress urinary incontinence and associated bother in women aged 40 and above; a Belgian epidemiological surveyInt J Clin Pract672013198204
   Web of Science ®Google Scholar
• N.KuritaS.YamazakiN.Fukumoriet alOveractive bladder symptom severity is associated with falls in community-dwelling adults. The LOHAS StudyBMJ Open32013e002413
   Web of Science ®Google Scholar
• P.RodriguesF.HeringJ.C.CampagnariInvoluntary detrusor contraction is a frequent finding in patients with recurrent urinary tract infectionsUrol Int9320146773
   Web of Science ®Google Scholar
• K.H.MooreA.P.MalykhinaWhat is the role of covert infection in detrusor overactivity, and other LUTD?Neurourol Urodyn332014606610
   Web of Science ®Google Scholar
• M.Espuña-PonsD.Castro-DíazH.Díaz-CuervoM.Pérezet alImpact of overactive bladder treatment on the quality of life of patients over 60 with associated pathologiesArch Esp Urol662013287294
   Web of Science ®Google Scholar
• D.L.PatrickK.M.KhalafR.DmochowskiJ.W.KowalskiD.R.Globeet alPsychometric performance of the incontinence quality-of-life questionnaire among patients with overactive bladder and urinary incontinenceClin Ther352013836845
   Web of Science ®Google Scholar
• J.P.Capo′V.LucenteS.Forero-SchwanhaeuserW.HeEfficacy and tolerability of solifenacin in patients aged >65 years with overactive bladder: post-hoc analysis of 2 open-label studiesPostgrad Med123201194104
   Web of Science ®Google Scholar
• A.WaggG.CompionA.FaheyE.SiddiquiPersistence with prescribed antimuscarinic therapy for overactive bladder: a UK experienceBJU Int110201217671774
   PubMed Web of Science ®Google Scholar
• K.J.MansfieldL.LiuF.J.MitchelsonK.H.MooreR.J.MillardE.BurcherMuscarinic receptor subtypes in human bladder detrusor and mucosa, studied by radioligand binding and quantitative competitive RT-PCR. changes in ageingBr J Pharmacol144200510891099
   PubMed Web of Science ®Google Scholar
• K.IkedaS.KobayashiM.SuzukiK.MiyataM.TakeuchiT.Yamadaet alM(3) receptor antagonism by the novel antimuscarinic agent solifenacin in the urinary bladder and salivary glandNaunyn Schmiedebergs Arch Pharmacol366200297103
   PubMed Web of Science ®Google Scholar
• A.OhtakeM.UkaiT.HatanakaS.KobayashiK.IkedaS.Satoet alIn vitro and in vivo tissue selectivity profile of solifenacin succinate (YM905) for urinary bladder over salivary gland in ratsEur J Pharmacol4922004243250
   PubMed Web of Science ®Google Scholar
• A.WaggJ.J.WyndaeleP.SieberEfficacy and tolerability of solifenacin in elderly subjects with overactive bladder syndrome: a pooled analysisAm J Geriatr Pharmacother420061424
   PubMedGoogle Scholar
• M.YoshidaK.MiyamaeH.IwashitaM.OtaniA.InadomeManagement detrusor dysfunction in the elderly: changes in acetylcholine and adenosine triphosphate release during agingUrology63Suppl. 120041723
   Google Scholar
• J.Y.ChunM.SongJ.Y.HanS.NaB.HongM.S.ChooClinical factors associated with dose escalation of solifenacin for the treatment of overactive bladder in real life practiceInt Neurourol J1820142330
   Web of Science ®Google Scholar
• R.NatalinF.LorenzettiM.DambrosManagement of OAB in those over age 65Curr Urol Report142013379385
   Web of Science ®Google Scholar
• B.AmendJ.HennenlotterT.SchäferM.HorstmannA.StenzlK.-D.SievertEffective treatment of neurogenic detrusor dysfunction by combined high-dosed antimuscarinics without increased side-effectsEur Urol53200810211028
   PubMed Web of Science ®Google Scholar
• K.S.KosilovS.LoparevM.IvanovskayaL.KosilovaManagement of overactive bladder (OAB) in elderly men and women with combined, high-dose antimuscarinics without increased side effectsUrotoday Int J62013 Art 47
   Google Scholar
• K.KosilovS.LoparevM.IvanovskayaL.KosilovaMaintenance of the therapeutic effect of two high-dosage antimuscarinics in the management of overactive bladder in elderly womenInt Neurourol J172013191196
   Web of Science ®Google Scholar
• K.S.KosilovS.LoparevM.IvanovskayaL.KosilovaEffectiveness of combined high-dosed trospium and solifenacin depending on severity of OAB symptoms in elderly men and women under cyclic therapyCent Eur J Urol6720144348
   Google Scholar
• K.S.CoyneT.ZyczynskiM.K.MargolisV.ElinoffR.G.Robertset alValidation of an overactive bladder awareness tool for use in primary care settingsAdv Ther222005381394
   PubMed Web of Science ®Google Scholar
• K.S.CoyneM.K.MargolisT.BavendamR.RobertsV.Elinoffet alValidation of a 3-item OAB awareness toolInt J Clin Pract652011219224
   PubMed Web of Science ®Google Scholar
• G.SinghM.LucasL.DolanS.KnightC.RamageP.Toozs HobsonMinimum standards for urodynamic practice in the UKNeurol Urodyn29201013651372
   PubMed Web of Science ®Google Scholar
• W.SchaferP.AbramsL.LiaoA.MattiassonF.PesceA.Spangberget alInternational Continence Society. Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow studiesNeurol Urodyn212002261274
   PubMed Web of Science ®Google Scholar
• C.M.GomesS.ArapF.E.Trigo-RochaVoiding dysfunction and urodynamic abnormalities in elderly patientsRev Hosp Clín Fac Med S Paulo592004206215
   Google Scholar
• M.ParsonsC.L.AmundsenL.CardozoM.VellaG.D.WebsterA.C.CoatsBladder diary patterns in detrusor overactivity and urodynamic stress incontinenceNeurourol Urodyn262007800806
   PubMed Web of Science ®Google Scholar
• C.L.AmundsenM.ParsonsL.CardozoM.VellaG.D.WebsterA.C.CoatsBladder diary volume per void measurements in detrusor overactivityJ Urol176200625302534
   PubMed Web of Science ®Google Scholar
• K.OkamuraY.NojiriM.YamamotoM.KobayashiY.OkamotoT.YasuiQuestionnaire survey on lower urinary tract symptoms (LUTS) for patients attending general practice clinicsNihon Ronen Igakkai Zasshi432006498504
   Google Scholar
• J.P.HeesakkersF.CruzY.IgawaE.KocjancicOveractive bladder: pathophysiology, diagnostics, and therapiesAdv Urol2011863504
   Google Scholar
• T.L.GrieblingOveractive bladder in elderly men: epidemiology, evaluation, clinical effects, and managementCurr Urol Report142013418425
   PubMed Web of Science ®Google Scholar
• K.E.AnderssonAntimuscarinics for treatment of overactive bladderLancet Neurol20044653
   Web of Science ®Google Scholar
• K.GiannitsasA.AthanasopoulosMale overactive bladder: pharmacotherapy for the maleCurr Opin Urol232013515519
   Web of Science ®Google Scholar
• E.HessdoerferK.JundtU.PeschersIs a dipstick test sufficient to exclude urinary tract infection in women with overactive bladder?Int Urogynecol J222011229232
   PubMed Web of Science ®Google Scholar
• S.MouttalibS.KhanE.Castel-LacanalJ.GuillotreauX.De BoissezonB.Malavaudet alRisk of urinary tract infection after detrusor botulinum toxin A injections for refractory neurogenic detrusor overactivity in patients with no antibiotic treatmentBJU Int106201016771680
   PubMed Web of Science ®Google Scholar
• T.Antunes-LopesC.D.CruzF.CruzK.D.SievertBiomarkers in lower urinary tract symptoms/overactive bladder: a critical overviewCurr Opin Urol242014352357
   PubMed Web of Science ®Google Scholar